LEPROSY REVIEW

Impact of socio-economic development, contact and peer counselling on stigma against persons affected by leprosy in Cirebon, Indonesia –a randomised controlled trial
Dadun D, Van Brakel WH, Peters RMH, Lusli M, Zweekhorst MBM, Bunders JGF and Irwanto
People affected by leprosy are often stigmatised, but stigma is rarely quantified and the effectiveness of interventions is often not evaluated. The SARI Project aimed to test and evaluate three interventions: counselling (involving peer counsellors), socio-economic development (SED) and contact between community members and affected people.
Knowledge, Attitudes and Practices relating to Leprosy among Public Health Care Providers in Colombo, Sri Lanka
Wijeratne MP and Østbye T
Leprosy remains a serious public health problem due to its ability to cause disability. The prevention of leprosy ultimately lies in the early diagnosis and treatment of the individuals having leprosy, thereby preventing further transmission. In Sri Lanka, 46% of new cases identified in year 2013, were late presentations and this caused to 7-8% patients to present with deformities. It has been observed that lack of awareness among health staff has contributed to this late diagnosis.
Cultural validation of a new instrument to measure leprosy-related stigma: the SARI Stigma Scale
Dadun , Peters RMH, Van Brakel WH, Lusli M, Damayanti R, Bunders JFG and Irwanto
There is a need for comprehensive, valid and reliable instruments to assess leprosy-related stigma. This paper presents the process of the cross-cultural validation of an instrument in Cirebon District, Indonesia initiated by the Stigma Assessment and Reduction of Impact (SARI) project.
Assessment of stigma among people living with Hansen’s disease in south-east Nigeria
Ibikunle PO and Nwokeji SC
The purpose of this study was to assess the stigma situation in Hansen’s disease from the perspective of both people affected by Hansen’s disease and those living in the surrounding community in southeast Nigeria.
Stigmatisation and discrimination: Experiences of people affected by leprosy in Southern Ghana
Dako-Gyeke M, Asampong E and Oduro R
Leprosy, a chronic infectious disease, poses a serious public health concern due to its impact on the wellbeing of affected people. This study, which was set in Ghana, explored stigmatisation and discrimination experiences of people affected by leprosy resident at the Weija Leprosarium in Accra.
Lucio phenomenon of leprosy LL type on pregnancy: A Rare Case
Prakoewswa CRS, Herwanto N, Agusni RI, Natalya FR, Listiawan MY, Adrity D, Wahyuni R, Iswahyudi I and Agusni I
Lucio phenomenon is a rare type of reaction in untreated, diffusely infiltrative form of lepromatous leprosy type, characterised with ulcerative type of skin lesions.
Autochthonous lepromatous leprosy in a Spanish woman with burns on both feet and skin lesions
Gómez-Camarasa C, Rodríguez-Granger J, Cañadas-Moreno O, Sampedro A, Aliaga-Martínez L and Cobo F
The incidence of leprosy is decreasing worldwide and it is considered a rare disease in developed countries. In Spain, leprosy is mainly an imported disease with only few autochthonous cases seen. The diagnosis is difficult because of a low index of suspicion and the absence of visualisation of fast-acid bacilli in the lesions. Here, we report an autochthonous case of leprosy diagnosed after 4 years of evolution of skin lesions. Mechanical rupture of the biopsy helped finally to make the correct diagnosis of the disease.
Strongyloides hyper infection in a steroid dependent leprosy patient
Darlong J
Immunosuppresion caused by corticosteroids predisposes leprosy patients to Strongyloides stercoralis infection which if untreated can be fatal. Patients acquire infection by walking barefoot in infested soils and can be infected for life because of the auto infective cycle of the parasite. Corticosteroids have precipitated death in more than 60% of disseminated strongyloidiasis cases.
Difficult diagnosis and challenging treatment – a report on leprosy
Marahatta S, Agrawal S and Paudyal P
Histoid leprosy is an unusual variant of lepromatous leprosy posing difficulties for diagnosis as well as treatment even to the experts. We report a case of a 73 year old male from the hilly region of Nepal, who presented with multiple asymptomatic scrotal nodules for 3 months. Though clinical diagnoses were pilomatricoma and steatocystoma multiplex; histopathological examination was consistent with that of histoid leprosy. After 10 months, he had unusual Type 2 lepra reaction with constitutional symptoms, perichondritis, epididymo-orchitis but without erythema nodosum leprosum. Two years later, his three family members were also affected with leprosy. Hence, this case is reported to highlight the diagnostic dilemma, complicated disease course and infectivity of histoid leprosy.
High resolution sonographic examination: a newer technique to study ulnar nerve neuropathy in leprosy
Gupta S, Bhatt S, Bhargava SK, Singal A and Bhargava S
A prospective case control study was conducted to calculate normal dimensions of ulnar nerve and study the size, echotexture and morphologic alterations in ulnar nerve in patients with leprosy.
Intrapatient comparison of Mycobacterium leprae by VNTR analysis in nasal secretions and skin biopsy in a Brazilian leprosy endemic region
Lima LNGC, Fontes ANB, Li W, Suffys PN, Vissa VD, Mota RMS, Almeida RLF, Pontes MA, Gonçales HS, Frota CC, Rodrigues LC, Kendall C and Kerr LRFS
This study compares the strains of genotypes of M. leprae from nasal secretions (NS) and skin biopsy (SB) in the same patient, supplementing conventional epidemiology to gain insight into the infection of leprosy in Fortaleza, Brazil.
19th International Leprosy Congress: the Plenary Sessions
Smith WCS
From the new ILA President
Johnson RC
Corticosteroid therapy in borderline tuberculoid leprosy patients co-infected with HIV undergoing reversal reaction: a clinical study
Secchin-De-Andrade PJ, De Andrea Vilas-Boas Hacker M, Sales AM, Dalvi-Garcia F, Da Costa Nery JA, Menezes VM and Sarno EN
Mycobacterium leprae and HIV cause infectious diseases of great concern for the public health care sector worldwide. Both are especially worrisome diseases when patients become co-infected and exhibit the expected clinical exuberance. The objective of this study was to evaluate episodes of reversal reaction (RR) and the effect of the use of corticosteroids on the treatment of borderline tuberculoid leprosy patients co-infected with the human immunodeficiency virus (HIV).
Letter to the Editor: Perspective of Sensory Ataxia in Leprosy
Khadilkar SV, Huchche AM, Patil ND, Singla M and Pandya SS
TlyA protein of Mycobacterium leprae: a probable bio-marker of active infection
Deval H, Katoch K, Chauhan DS, Tyagi AK, Gupta RK, Kamal R, Kumar A, Yadav VS, Katoch VM and Hussain T
The extent of pathogenicity of the mycobacterial infections depends on virulence factors that mediate survival inside macrophages. Virulence factors are generally believed to be specific for pathogenic species and mutated/non-functional in nonpathogenic strains. Mycobacterial TlyA can modulate the phagolysosome maturation pathway, immediately after entry into macrophages. Over-expression of open reading frame (ORF) ML1358 (tlyA) in tissues of leprosy patients by partial DNA chip and real time PCR analysis during active infection attracted our interest to explore the properties of this gene at molecular and serological levels, to understand its role in the host. Molecular properties were studied by cloning and expression of the corresponding gene in pASK-iba 43(þ) expression vector in E. coli and bioinformatics tools while sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and ELISA were applied to investigate the serological significance of rTlyA protein in different clinical states of leprosy. We observed that TlyA has a close relation among mycobacteria with specific protein domains in slow growing intracellular adapted pathogenic species. The presence of trans-membrane domains indicates its association to the cell membrane. The study revealed its highly significant sero-reactivity (P value , 0·001) in borderline lepromatous (BL) patients, and those with reversal reaction (RR) and erythema nodosum leprosum (ENL). Its role in active infection, association with the cell membrane, presence in pathogenic species and high sero-reactivity, suggested the tlyA gene as a strong disease progression marker.
Protocol for a Randomised Controlled Trial Investigating Decompression for Leprous Neuropathy (The DELN Protocol)
Wan EL, Rivadeniera AF, Serrano HA, Napit I, Garbino JA, Joshua J, Cardona-Castro N, Dellon AL and Theuvenet W
An expert group of peripheral nerve surgeons, reconstructive surgeons, and immunologists who have extensive experience with Hansen’s Disease convened to discuss the status of nerve decompression as a treatment for leprous neuropathy. The expert group recommended an international, multi-center randomised controlled trial (RCT). Subsequently, a study protocol called Decompression for Leprous Neuropathy (DELN) was designed and further refined by multiple investigators worldwide.
Spatial distribution of leprosy in Nigeria
Daniel OJ, Adejumo OA, Oritogun KS, Omosebi O, Kuye J and Akang G
Despite achieving the WHO elimination target of less than 1/10,000 population in 1998 at the national level, there are still pockets of relative high endemicity of leprosy in Nigeria. This study used spatial analytic techniques to determine the spatial distribution of leprosy in Nigeria.
Adaptive shortening of long flexor in patients with claw hand: A short report
Gupta P, Joshua KK and Jahan T
Adaptive shortening of long flexors is the common secondary impairment which can occur in patients with long standing claw hand, particularly in those who do not undergo any supervised physiotherapy programme.¹ The main purpose of this short report is to describe the current physiotherapeutic means which are commonly employed for the management of long flexor tightness. This report further gives an insight into the consequences of the delay in corrective surgery and ultimately describes the dire need for further research on this deformity.² Adaptive shortening of the muscles is a phenomenon which can occur for many reasons, like prolonged immobilisation of the of the body segment, postural imbalance, muscle imbalance, impaired muscle performance due to neuromuscular problems or may be due congenital and acquired deformity.Tightness of the muscles leads to limitation of joint range of motion.³ In leprosy the cause of adaptive shortening of the long flexors is muscle imbalance which occurs due to paralysis of the ulnar nerve at the elbow joint. Adaptive shortening of the muscles is a secondary impairment.⁴ Secondary impairments have multidimensional effects on the management of the deformity, including delay in surgery for the correction of deformity which in turn is responsible for the unemployment, social stigma and problems in social integration.⁵ Secondary impairment in some way or other is responsible for the above stated problems, but adaptive shortening of the long flexor (long flexor tightness) is important because sometimes months of therapy are required to attain full muscle length.
A critical appraisal on pure neuritic leprosy from India after achieving WHO global target of leprosy elimination
Narang T, Vinay K, Kumar S and Dogra S
Clinical data on pure-neuritic leprosy (PNL) is limited.
The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis
Steinmann P, Cavaliero A, Aerts A, Anand S, Arif M, Ay SS, Aye TM, Barth-Jaeggi T, Banstola NL, Bhandari CM, Blaney D, Bonenberger M, VAN Brakel W, Cross H, DAS VK, Fahrudda A, Fernando N, Gani Z, Greter H, Ignotti E, Kamara D, Kasang C, Kömm B, Kumar A, Lay S, Mieras L, Mirza F, Mutayoba B, Njako B, Pakasi T, Saunderson P, Shengelia B, Smith CS, Stäheli R, Suriyarachchi N, Shwe T, Tiwari A, Wijesinghe MSD, VAN Berkel J, Vander Plaetse B, Virmond M and Richardus JH
Innovative approaches are required to further enhance leprosy control, reduce the number of people developing leprosy, and curb transmission. Early case detection, contact screening, and chemoprophylaxis currently is the most promising approach to achieve this goal. The Leprosy Post-Exposure Prophylaxis (LPEP) programme generates evidence on the feasibility of integrating contact tracing and single-dose rifampicin (SDR) administration into routine leprosy control activities in different settings. The LPEP programme is implemented within the leprosy control programmes of Brazil, Cambodia, India, Indonesia, Myanmar, Nepal, Sri Lanka and Tanzania. Focus is on three key interventions: tracing the contacts of newly diagnosed leprosy patients; screening the contacts for leprosy; and administering SDR to eligible contacts. Country-specific protocol adaptations refer to contact definition, minimal age for SDR, and staff involved. Central coordination, detailed documentation and rigorous supervision ensure quality evidence. Around 2 years of field work had been completed in seven countries by July 2017. The 5,941 enrolled index patients (89·4% of the registered) identified a total of 123,311 contacts, of which 99·1% were traced and screened. Among them, 406 new leprosy patients were identified (329/100,000), and 10,883 (8·9%) were excluded from SDR for various reasons. Also, 785 contacts (0·7%) refused the prophylactic treatment with SDR. Overall, SDR was administered to 89·0% of the listed contacts. Post-exposure prophylaxis with SDR is safe; can be integrated into the routines of different leprosy control programmes; and is generally well accepted by index patients, their contacts and the health workforce. The programme has also invigorated local leprosy control.